Monogram Orthopaedics (MGRM) Competitors $6.00 0.00 (0.00%) As of 10/7/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRM vs. INMD, IRMD, BBNX, EMBC, AXGN, TNDM, SIBN, CLPT, BVS, and ZIMVShould you be buying Monogram Orthopaedics stock or one of its competitors? The main competitors of Monogram Orthopaedics include InMode (INMD), iRadimed (IRMD), Beta Bionics (BBNX), Embecta (EMBC), AxoGen (AXGN), Tandem Diabetes Care (TNDM), SiBone (SIBN), ClearPoint Neuro (CLPT), Bioventus (BVS), and ZimVie (ZIMV). These companies are all part of the "medical equipment" industry. Monogram Orthopaedics vs. Its Competitors InMode iRadimed Beta Bionics Embecta AxoGen Tandem Diabetes Care SiBone ClearPoint Neuro Bioventus ZimVie Monogram Orthopaedics (NASDAQ:MGRM) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership. Which has stronger valuation and earnings, MGRM or INMD? InMode has higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMonogram OrthopaedicsN/AN/A-$16.33M-$0.50-12.00InMode$394.82M2.44$181.27M$2.476.18 Do insiders and institutionals hold more shares of MGRM or INMD? 0.4% of Monogram Orthopaedics shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 28.1% of Monogram Orthopaedics shares are owned by insiders. Comparatively, 6.9% of InMode shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more risk & volatility, MGRM or INMD? Monogram Orthopaedics has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, InMode has a beta of 2.09, indicating that its share price is 109% more volatile than the S&P 500. Does the media favor MGRM or INMD? In the previous week, InMode had 8 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 13 mentions for InMode and 5 mentions for Monogram Orthopaedics. Monogram Orthopaedics' average media sentiment score of 0.50 beat InMode's score of 0.31 indicating that Monogram Orthopaedics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Monogram Orthopaedics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InMode 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer MGRM or INMD? Monogram Orthopaedics presently has a consensus target price of $5.40, suggesting a potential downside of 10.00%. InMode has a consensus target price of $18.21, suggesting a potential upside of 19.24%. Given InMode's higher possible upside, analysts clearly believe InMode is more favorable than Monogram Orthopaedics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Monogram Orthopaedics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67InMode 1 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is MGRM or INMD more profitable? InMode has a net margin of 44.50% compared to Monogram Orthopaedics' net margin of 0.00%. InMode's return on equity of 18.38% beat Monogram Orthopaedics' return on equity.Company Net Margins Return on Equity Return on Assets Monogram OrthopaedicsN/A -126.82% -96.87% InMode 44.50%18.38%16.35% SummaryInMode beats Monogram Orthopaedics on 11 of the 15 factors compared between the two stocks. Get Monogram Orthopaedics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRM vs. The Competition Export to ExcelMetricMonogram OrthopaedicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$243.79M$6.85B$6.01B$10.23BDividend YieldN/A1.16%5.66%4.69%P/E Ratio-12.0026.2985.3526.57Price / SalesN/A189.69582.95179.01Price / CashN/A22.0838.3262.20Price / Book14.295.1112.726.53Net Income-$16.33M$178.04M$3.30B$275.87M7 Day Performance-1.80%-2.07%1.07%-1.40%1 Month Performance3.09%8.24%7.61%5.16%1 Year Performance154.24%27.37%79.71%31.51% Monogram Orthopaedics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRMMonogram Orthopaedics0.9232 of 5 stars$6.00flat$5.40-10.0%N/A$243.79MN/A-12.0028News CoverageAnalyst ForecastINMDInMode2.8031 of 5 stars$14.82-1.2%$18.04+21.8%+5.6%$938.91M$401.56M6.01480Trending NewsAnalyst ForecastIRMDiRadimed4.6008 of 5 stars$69.63-0.6%$72.00+3.4%+52.7%$885.44M$73.24M42.97110Analyst ForecastInsider TradeBBNXBeta Bionics2.0401 of 5 stars$19.69-0.9%$23.33+18.5%N/A$855.92M$65.12M0.00294Analyst ForecastInsider TradeGap UpEMBCEmbecta4.674 of 5 stars$13.85-1.1%$19.00+37.2%+4.1%$810.31M$1.10B9.692,100News CoverageAnalyst DowngradeAXGNAxoGen3.0361 of 5 stars$17.65+2.3%$25.75+45.9%+19.6%$809.09M$187.34M-175.83450Analyst ForecastTNDMTandem Diabetes Care4.1117 of 5 stars$11.56-2.0%$22.44+94.1%-62.1%$782.38M$1.00B-3.752,650Analyst ForecastSIBNSiBone3.9053 of 5 stars$14.44+1.9%$23.67+64.0%+22.4%$622.73M$167.18M-25.78350Analyst ForecastCLPTClearPoint Neuro0.5961 of 5 stars$21.73+0.7%$19.67-9.5%+138.7%$617.07M$31.39M-26.80110Analyst ForecastBVSBioventus3.2766 of 5 stars$6.67+0.8%$13.75+106.1%-42.5%$550.64M$564.14M-10.921,200ZIMVZimVie1.3147 of 5 stars$18.92+0.1%$17.75-6.2%+20.1%$533.61M$443.40M-27.021,770News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies InMode Competitors iRadimed Competitors Beta Bionics Competitors Embecta Competitors AxoGen Competitors Tandem Diabetes Care Competitors SiBone Competitors ClearPoint Neuro Competitors Bioventus Competitors ZimVie Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRM) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monogram Orthopaedics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monogram Orthopaedics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
